drugset / Trial / NCT06880042
COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO
RandomizedParallel-groupOpen-labelTreatment
Summary
Patient of stable and limited vitiligo less than 20% BSA will be recruited And evaluation of efficacy and safety of narrowband UVB with topical tacrolimus vs narrowband UVB and calcipotriol will be assessed
Timeline
- Start
- 2025-05-01
- Primary completion
- 2025-06-30
- Completion
- 2025-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Calcipotriol | Small molecule | 0.005 % | — |
| Comparator | Tacrolimus | Small molecule | 0.1 % | Topical |